ReviewExploration of targeted anti-tumor therapy2024
Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer.
Thomas Hansen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.